BR0110098A - Polinucleotìdeo, construção genética recombinante, vetor de expressão, célula hospedeira, animal transgênico, peptìdeo, métodos para triagem de um agente quanto à atividade farmacológica, de inibir a ligação do gnrh a seu receptor nativo in vivo, e de contracepção, e, usos do gnrh-r do tipo ii ou de um seu domìnio extracelular - Google Patents

Polinucleotìdeo, construção genética recombinante, vetor de expressão, célula hospedeira, animal transgênico, peptìdeo, métodos para triagem de um agente quanto à atividade farmacológica, de inibir a ligação do gnrh a seu receptor nativo in vivo, e de contracepção, e, usos do gnrh-r do tipo ii ou de um seu domìnio extracelular

Info

Publication number
BR0110098A
BR0110098A BR0110098-0A BR0110098A BR0110098A BR 0110098 A BR0110098 A BR 0110098A BR 0110098 A BR0110098 A BR 0110098A BR 0110098 A BR0110098 A BR 0110098A
Authority
BR
Brazil
Prior art keywords
gnrh
type
polynucleotide
peptide
screening
Prior art date
Application number
BR0110098-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Robert Peter Millar
Steven Lowe
Darrel Conklin
Original Assignee
Medical Res Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0009269A external-priority patent/GB0009269D0/en
Priority claimed from GB0014761A external-priority patent/GB0014761D0/en
Application filed by Medical Res Council filed Critical Medical Res Council
Publication of BR0110098A publication Critical patent/BR0110098A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BR0110098-0A 2000-04-15 2001-04-17 Polinucleotìdeo, construção genética recombinante, vetor de expressão, célula hospedeira, animal transgênico, peptìdeo, métodos para triagem de um agente quanto à atividade farmacológica, de inibir a ligação do gnrh a seu receptor nativo in vivo, e de contracepção, e, usos do gnrh-r do tipo ii ou de um seu domìnio extracelular BR0110098A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0009269A GB0009269D0 (en) 2000-04-15 2000-04-15 Receptor
GB0014761A GB0014761D0 (en) 2000-06-17 2000-06-17 Receptor
US21523200P 2000-06-30 2000-06-30
PCT/GB2001/001755 WO2001078796A1 (fr) 2000-04-15 2001-04-17 Recepteur de la gonadoliberine de type ii et polynucleotides codant pour ce recepteur

Publications (1)

Publication Number Publication Date
BR0110098A true BR0110098A (pt) 2003-01-14

Family

ID=27255670

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0110098-0A BR0110098A (pt) 2000-04-15 2001-04-17 Polinucleotìdeo, construção genética recombinante, vetor de expressão, célula hospedeira, animal transgênico, peptìdeo, métodos para triagem de um agente quanto à atividade farmacológica, de inibir a ligação do gnrh a seu receptor nativo in vivo, e de contracepção, e, usos do gnrh-r do tipo ii ou de um seu domìnio extracelular

Country Status (11)

Country Link
EP (1) EP1337282A2 (fr)
JP (1) JP2003530837A (fr)
KR (1) KR20020097218A (fr)
AU (1) AU2001248599A1 (fr)
BR (1) BR0110098A (fr)
CA (1) CA2404127A1 (fr)
HU (1) HUP0301666A2 (fr)
IL (1) IL152011A0 (fr)
NO (1) NO20024937L (fr)
PL (1) PL357684A1 (fr)
WO (1) WO2001078796A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001281882A1 (en) * 2000-06-26 2002-01-08 Bayer Aktiengesellschaft Regulation of human gonadotropin releasing hormone receptor-like g protein-coupled receptor
WO2002070701A2 (fr) * 2001-03-01 2002-09-12 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Nouveau recepteur gnrh humain
US20050282745A1 (en) * 2001-08-28 2005-12-22 Siler-Khodr Theresa M Non-mammalian GnRH analogs and uses thereof in regulation of fertility and pregnancy
US7361633B2 (en) 2002-07-22 2008-04-22 Ardana Bioscience Limited Screening method and anti-tumor drug candidate obtained therefrom
WO2004010145A2 (fr) * 2002-07-22 2004-01-29 Ardana Bioscience Limited Procede de criblage
WO2004009636A2 (fr) * 2002-07-22 2004-01-29 Ardana Bioscience Limited Modulateur de la gnrh
KR101038183B1 (ko) * 2010-12-27 2011-06-01 강범준 조립식 파형블록과 이를 이용한 호안 경사면 피복방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0647275T3 (da) * 1992-06-23 2005-01-24 Sinai School Medicine Kloning og ekspression af receptoren for gonatotropin-frigörende hormon
AU3388597A (en) * 1996-06-13 1998-01-07 University Of Cape Town Human type ii gonadotropin-releasing hormone receptor

Also Published As

Publication number Publication date
PL357684A1 (en) 2004-07-26
NO20024937L (no) 2002-12-09
WO2001078796A9 (fr) 2002-02-28
HUP0301666A2 (hu) 2003-08-28
EP1337282A2 (fr) 2003-08-27
KR20020097218A (ko) 2002-12-31
CA2404127A1 (fr) 2001-10-25
NO20024937D0 (no) 2002-10-14
AU2001248599A1 (en) 2001-10-30
WO2001078796A3 (fr) 2003-04-24
IL152011A0 (en) 2003-04-10
WO2001078796A1 (fr) 2001-10-25
JP2003530837A (ja) 2003-10-21

Similar Documents

Publication Publication Date Title
BR0113921A (pt) ácidos nucléicos e polipeptìdeos receptores
AR006188A1 (es) "composicion farmaceutica para inhibir la actividad de serinproteasa, metodo in vitro para inhibir la actividad de serinproteasa y metodo para preparar dicha composicion".
Fischer-Colbrie et al. Sequence analysis, tissue distribution and regulation by cell depolarization, and second messengers of bovine secretogranin II (chromogranin C) mRNA.
PH12013502425A1 (en) Smoothened polypeptides and methods of use
WO2004069876A3 (fr) Reponse de lymphocyte t durable
DE60140218D1 (de) Expressionsvektor für tierische zellen
DE69939327D1 (de) Funktionelle antagonisten von hedgehog-aktivität
Albert et al. Direct synthesis of [DOTA-DPhe1]-octreotide and [DOTA-DPhe1, Tyr3]-octreotide (SMT487): two conjugates for systemic delivery of radiotherapeutical nuclides to somatostatin receptor positive tumors in man
BR0110098A (pt) Polinucleotìdeo, construção genética recombinante, vetor de expressão, célula hospedeira, animal transgênico, peptìdeo, métodos para triagem de um agente quanto à atividade farmacológica, de inibir a ligação do gnrh a seu receptor nativo in vivo, e de contracepção, e, usos do gnrh-r do tipo ii ou de um seu domìnio extracelular
ATE293169T1 (de) Latency associated peptide von tgf-beta um pharmazeutisch aktive proteine latent zu machen
KR960704932A (ko) 당단백질 호르몬 4개조의 단일-사슬 형태(single-chain forms of the glycoprotein hormone quartet)
Yotov et al. Nucleotide sequence of a mouse cDNA encoding the nonhistone chromosomal high mobility group protein-1 (HMG1).
BR0010563A (pt) Composições isoladas de células da pele e métodos para seu uso
WO2002050111A3 (fr) Laminine 10 isolee
PT1007559E (pt) Celulas geneticamente modificadas que expressam as proteinas morfogeneticas do osso
BR9812138A (pt) Métodos e composições para terapias empregando genes codificando proteìnas segregadas tal como interferon-beta
DE69935599D1 (de) Modifizierte hcv peptid-impfstoffe
ATE364392T1 (de) Zusammensetzung aus liganden/lytischen petiden und ihre verwendung
ATE294816T1 (de) Neue, physiologisch aktive peptide und ihre verwendung.
WO2002070657A3 (fr) 93870, recepteur couple a la proteine g humaine et ses utilisations
Anderson Stress proteins and apoptosis in prenatal development, cancer and medicine
DE60142356D1 (de) 18480 humane proteinkinasemoleküle und ihre verwendungen
WO2002013845A3 (fr) Inflammation associee au recepteur couple a la proteine g
IL138585A0 (en) Vertebrate batched -2 protein
Elkon Ribosomal RNP

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]